Charles River, Labcorp and FDA collaborate to validate preclinical methods for abuse potential assessment
LH•Charles River, Labcorp and the FDA are collaborating to validate new preclinical methods for assessing abuse potential. Their agreement establishes a joint framework for standardized abuse-potential metrics in preclinical models.
1. Joint validation framework
Charles River Laboratories International, Labcorp and the FDA are collaborating to validate new preclinical methods for abuse-potential assessment. The agreement establishes a joint framework for standardized abuse-potential metrics in preclinical models.
